The deal for the privately held U.K.-based biotechnology agency will assist bolster Novartis’s oncology capabilities.
Source link
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Related Posts
Blue Origin launchpad may not be restored until 2028: NASA’s Isaacman
NASA Administrator Jared Isaacman on Monday instructed CNBC that it’s going to “take some severe time” to revive the launchpad…
Google Fined $3.5 Billion by EU Over Ad-Tech Business
The European Union fined Google nearly $3.5 billion for abusing the dominance of its advertising-technology tools—a move that immediately stirred…
Nvidia Unveils Faster AI Chips Sooner Than Expected
On the Client Electronics Present in Las Vegas, CEO Jensen Huang stated extra highly effective chips will allow coaching of…